IL33 and heart failure: Nevertheless, studies on cardiomyocytes demonstrated that IL-33 might increase the activity of antioxidant enzymes and decrease oxidative stress; however, sST2 prevented this effect, indicating a complicated interplay between these biomarkers in heart failure [84].